XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of Net Sales and Profit by Segments Net sales and profit by each reportable segment for the three months ended March 31, 2021 and 2020 are as follows :
Three Months Ended March 31,
 20212020
(In thousands)
Segment Net Sales
Codman Specialty Surgical$241,241 $231,440 
Tissue Technologies
118,830 122,884 
Total revenues$360,071 $354,324 
Segment Profit
Codman Specialty Surgical$106,778 $87,235 
Tissue Technologies
50,011 31,271 
Segment profit156,789 118,506 
Amortization(4,527)(6,977)
Corporate and other(121,548)(84,426)
Operating income$30,714 $27,103 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
 20212020
 (In thousands)
United States$247,793 $246,852 
Europe45,819 45,896 
Asia Pacific47,295 39,960 
Rest of World19,164 21,616 
Total Revenues$360,071 $354,324 
Schedule of Geographic Revenue by Area Net sales and profit by each reportable segment for the three months ended March 31, 2021 and 2020 are as follows :
Three Months Ended March 31,
 20212020
(In thousands)
Segment Net Sales
Codman Specialty Surgical$241,241 $231,440 
Tissue Technologies
118,830 122,884 
Total revenues$360,071 $354,324 
Segment Profit
Codman Specialty Surgical$106,778 $87,235 
Tissue Technologies
50,011 31,271 
Segment profit156,789 118,506 
Amortization(4,527)(6,977)
Corporate and other(121,548)(84,426)
Operating income$30,714 $27,103 
Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
 20212020
 (In thousands)
United States$247,793 $246,852 
Europe45,819 45,896 
Asia Pacific47,295 39,960 
Rest of World19,164 21,616 
Total Revenues$360,071 $354,324